BiotechTube
InnoPep

InnoPep

San Diego, United States· Est.
innopep.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15.5M

Overview

InnoPep is a private, revenue-generating service provider in the life sciences tools and reagents sector, focusing on custom peptide and antibody production. Founded by experienced researchers, the company leverages decades of technical expertise in peptide synthesis to offer rapid, high-quality services, including rush orders and complex modifications, from its fully staffed lab in San Diego. Its business model is built on a direct-to-researcher online platform featuring instant quoting and ordering, catering primarily to preclinical research needs in oncology and immunology. While not developing its own therapeutic pipeline, InnoPep plays a supporting role in the broader drug discovery ecosystem by providing essential research components.

OncologyImmunology

Technology Platform

Integrated service platform for custom peptide synthesis and conjugation, specializing in long peptides (up to 100 aa), stapled peptides, glycopeptides, dye-labeling, and antibody services. Supported by an online instant quotation and ordering system.

Funding History

2
Total raised:$15.5M
Series A$12M
Seed$3.5M

Opportunities

Growing demand for complex, custom research reagents in oncology and immunology R&D, driven by increased focus on peptide therapeutics and personalized medicine.
The shift towards outsourcing specialized lab work and the need for rapid, reliable suppliers in biotech hubs like San Diego presents a stable market opportunity.
Expansion into adjacent service areas like peptide libraries or preferred partnerships with larger research organizations could provide growth avenues.

Risk Factors

Faces intense competition from both large reagent conglomerates and numerous small peptide shops, primarily on price and turnaround time.
Revenue is tied to cyclical R&D spending from academic and biotech clients, making it susceptible to funding downturns.
The custom service model has scalability challenges and depends heavily on retaining key technical personnel and maintaining consistent quality on complex syntheses.

Competitive Landscape

Operates in a highly fragmented and competitive market for custom peptide synthesis. Competitors range from global giants like GenScript and Thermo Fisher to many small, specialized CROs. InnoPep differentiates by emphasizing technical expertise in long and complex peptides (stapled, glycopeptides), a user-friendly digital interface, and a focus on rush services, targeting researchers who value a nimble, expert partner over the lowest-cost, high-volume providers.

More companies in Small Molecule Drugs →More companies in United States →